Patent · US Active

IRAK inhibitors and uses thereof

US9340554B2 · kind B2 · utility

8Cited by
5References
9Claims
0Family size

Assignee

Inventors

Key dates

Filing dateFeb 25, 2014
Grant dateMay 17, 2016
Priority date
Expiry dateFeb 25, 2034

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D495/04
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention provides 5,6,7,8-tetrahydrobenzo[4,5]thieno[2,3-d]pyrimidine compounds and pharmaceutical compositions thereof as inhibitors of IRAK.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.